BioXcel Therapeutics, Inc. (BTAIQ): key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- $642.0K
- Net Income/Loss (FY2025)
- -$69.9M
- Total Assets (FY2025)
- $44.9M
- Total Equity (FY2025)
- -$95.5M
- Cash Flows from Operating Activities (FY2025)
- -$57.6M
Source: BioXcel Therapeutics, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
